Effect of Fear of Litigation on Obstetric Care: A Nationwide Analysis on Obstetric Practice

2011 ◽  
Vol 28 (04) ◽  
pp. 277-284 ◽  
Author(s):  
Philip Zwecker ◽  
Laurent Azoulay ◽  
Haim Abenhaim
2019 ◽  
Vol 47 (2) ◽  
pp. 152-160 ◽  
Author(s):  
Sebastian Rupert Hobson ◽  
Merihan Zarif Abdelmalek ◽  
Dan Farine

Abstract Uterine tachysystole (TS) is a potentially significant intrapartum complication seen most commonly in induced or augmented labors but may also occur in women with spontaneous labor. When it occurs, maternal and perinatal complications can arise if not identified and managed promptly by obstetric care providers. Over recent years, new definitions of the condition have facilitated further research into the field, which has been synthesized to inform clinical management guidelines and protocols. We propose a set of recommendations pertaining to TS in line with contemporary evidence and obstetric practice.


2005 ◽  
Vol 61 (7) ◽  
pp. 1408-1417 ◽  
Author(s):  
Wachara Riewpaiboon ◽  
Komatra Chuengsatiansup ◽  
Lucy Gilson ◽  
Viroj Tangcharoensathien

Anaesthesia ◽  
2001 ◽  
Vol 56 (10) ◽  
pp. 1023-1024 ◽  
Author(s):  
F. Plaat ◽  
L. McCready-Hall

2016 ◽  
pp. 11-18
Author(s):  
L. Nazarenko ◽  
◽  
L. Dubrova ◽  
O. Tarusмna ◽  
◽  
...  

The question of the prevention of pathologies of the labor is currently very important, the answer to them has become the favored formation of «dominants of delivery», choice of the optimal time to delivery, effective and safe method of induction, that promotes the promptness of the female organism and ripening of the cervix, as well as the timely identification and correction of pathological prelмmмnary period. In a review article describes the modern approaches and methods of preventing the pathology of labor activity, presented by the authors ‘ own experience regarding the use of prostaglandins, non-steroidal anti-inflammatory drugs, individual approach to the management of perinatal risk. Key words: childbirth, prevention, induction, prostaglandin, non-steroidal anti-inflammatory drugs.


2017 ◽  
pp. 19-24
Author(s):  
O.V. Grishchenko ◽  
◽  
V.V. Bobrytska ◽  

The objective: To evaluate the clinical efficacy and safety of Enoxaparin-Pharmex for the prevention of thrombotic complications (pulmonary embolism) in the postoperative period in patients with moderate risk of these complications. Patients and methods. The study included 50 women after a caesarean section had an average degree of risk of pulmonary embolism. Patients were divided into the main group (n=25) and control group (n=25) in accordance with the treatment: patients of the main group received postoperative Еnoxaparin- Pharmex, group comparisons enoxaparin sodium (brand foreign manufacturer’s). Patients in both groups received the drug at a dose of 20 mg for 5 days, 1 time per day subcutaneously. Results. The research data analysis showed identity results of hemostasiogram of patients in the main group and the comparison group, no side effects after treatment in both groups. Conclusion. The clinical studies suggest the drug Enoxaparin-Pharmex is effective, safe LMWH, which can be used to prevent troboembolic complications, including post-operative treatment in obstetric practice. Spectrum of Enoxaparin-Pharmex can be extended to the prevention and treatment of thromboembolic conditions of varying severity with appropriate doses of the drug. Key words: Enoxaparin-Pharmex, prevention of pulmonary embolism.


GYNECOLOGY ◽  
2014 ◽  
Vol 16 (2) ◽  
pp. 82-84
Author(s):  
Yu.B. Uspenskaya ◽  
Keyword(s):  

2018 ◽  
Vol 13 (2) ◽  
pp. 64-66
Author(s):  
Alexander Bambala Kawimbe

Rectovaginal fistula is an abnormal communication between the rectum and the vaginal. This leads to uncontrollable passage of feces and flatus through the vagina. It therefore causes distressing physical, social and psychological symptoms on the affected woman. The commonest cause of Rectovaginal Fistula is obstetric trauma commonly in developing countries with poor access to Obstetric care or substandard care provision. The case reported here highlights a rare situation in which a birth control measure of Intrauterine Contraceptive Device (IUD) in a 36 years old healthy female leads to a high Rectovaginal fistula.Keywords: fecal incontinence, missing IUD, rectovaginal fistula


Sign in / Sign up

Export Citation Format

Share Document